Cambria Investment Management, L.P. Biogen Inc. Transaction History

Cambria Investment Management, L.P.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$193.77 - $244.14 $2.28 Million - $2.87 Million	-11,772 Closed	0 $0
Q4 2021 Feb 03, 2022	BUY	$223.92 - $287.77 $268,480 - $345,036	1,199 Added 11.34%	11,772 $2.82 Million
Q3 2021 Oct 26, 2021	SELL	$282.99 - $369.05 $123,383 - $160,905	-436 Reduced 3.96%	10,573 $2.99 Million
Q2 2021 Aug 12, 2021	BUY	$259.0 - $414.71 $395,234 - $632,847	1,526 Added 16.09%	11,009 $3.81 Million
Q1 2021 May 11, 2021	BUY	$242.95 - $284.63 $1.69 Million - $1.98 Million	6,967 Added 276.91%	9,483 $2.65 Million
Q4 2020 Feb 04, 2021	SELL	$236.26 - $355.63 $32,131 - $48,365	-136 Reduced 5.13%	2,516 $616,000
Q3 2020 Nov 13, 2020	SELL	$264.77 - $305.71 $45,275 - $52,276	-171 Reduced 6.06%	2,652 $752,000
Q2 2020 Aug 10, 2020	SELL	$258.66 - $342.55 $145,366 - $192,513	-562 Reduced 16.6%	2,823 $755,000
Q1 2020 May 15, 2020	SELL	$268.85 - $341.04 $132,005 - $167,450	-491 Reduced 12.67%	3,385 $1.07 Million
Q4 2019 Feb 12, 2020	BUY	$220.06 - $304.07 $852,952 - $1.18 Million	3,876 New	3,876 $1.15 Million

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Cambria Investment Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Cambria Investment Management, L.P. with notifications on news.